- Home
- KNDI vs VTGN Comparison
KNDI vs VTGN Comparison
Compare KNDI & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- VTGN
- Stock Information
- Founded
- KNDI 2002
- VTGN 1998
- Country
- KNDI China
- VTGN United States
- Employees
- KNDI N/A
- VTGN N/A
- Industry
- KNDI Auto Manufacturing
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- VTGN Health Care
- Exchange
- KNDI Nasdaq
- VTGN Nasdaq
- Market Cap
- KNDI 101.7M
- VTGN 129.8M
- IPO Year
- KNDI N/A
- VTGN N/A
- Fundamental
- Price
- KNDI $1.25
- VTGN $4.07
- Analyst Decision
- KNDI
- VTGN
- Analyst Count
- KNDI 0
- VTGN 0
- Target Price
- KNDI N/A
- VTGN N/A
- AVG Volume (30 Days)
- KNDI 107.7K
- VTGN 541.5K
- Earning Date
- KNDI 11-17-2025
- VTGN 11-07-2025
- Dividend Yield
- KNDI N/A
- VTGN N/A
- EPS Growth
- KNDI N/A
- VTGN N/A
- EPS
- KNDI N/A
- VTGN N/A
- Revenue
- KNDI $104,035,613.00
- VTGN $646,000.00
- Revenue This Year
- KNDI N/A
- VTGN $9.14
- Revenue Next Year
- KNDI N/A
- VTGN $467.87
- P/E Ratio
- KNDI N/A
- VTGN N/A
- Revenue Growth
- KNDI N/A
- VTGN N/A
- 52 Week Low
- KNDI $0.89
- VTGN $1.90
- 52 Week High
- KNDI $1.81
- VTGN $4.52
- Technical
- Relative Strength Index (RSI)
- KNDI 48.18
- VTGN 58.27
- Support Level
- KNDI $1.21
- VTGN $3.90
- Resistance Level
- KNDI $1.29
- VTGN $4.38
- Average True Range (ATR)
- KNDI 0.06
- VTGN 0.30
- MACD
- KNDI 0.01
- VTGN -0.01
- Stochastic Oscillator
- KNDI 33.18
- VTGN 39.29
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.